abrdn Life Sciences Investors
About abrdn Life Sciences Investors
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Market cap
- $514.5M
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $514.5M
- Dividend yield
- 13.44%
- Shares outstanding
- 30.9M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- May 1, 1992
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Trading 9% below its 52-week high.
- Pays a dividend yielding about 13.44% annually.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review abrdn Life Sciences Investors.
Write a review
News about abrdn Life Sciences Investors
News & sentiment via Polygon.io
